Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cassiman

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
Clinical Chemistry and Laboratory Medicine|April 17, 2012
Evaluation of the interference by homogentisic acid and other organic acids on the enzymatic and Jaffé method creatinine assaySteven Pauwels, David Cassiman, Pieter Vermeersch
Orphanet Journal of Rare Diseases|September 12, 2014
Reimbursement of orphan drugs in Belgium: what (else) matters?Eline Picavet, David Cassiman, Steven Simoens
Health Policy (Amsterdam, Netherlands)|September 20, 2012
Evaluating and improving orphan drug regulations in Europe: a Delphi policy studyEline Picavet, David Cassiman, Steven Simoens
Journal of Hepatology|March 8, 2024
Rare monogenic causes of steatotic liver disease masquerading as MASLDMartijn C G J Brouwers, David Cassiman
Journal of Inherited Metabolic Disease|October 2, 2021
Patents vs patients 1-0: The case of chenodeoxycholic acidSarah Marie Briké, Wouter Meersseman, David Cassiman
Gastroenterology|September 1, 2014
Hepatitis with brown pigment in the liverHannah van Malenstein, Louis Libbrecht, David Cassiman
Molecular Genetics and Metabolism|April 22, 2019
Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseasesCarlos R Ferreira, David Cassiman, Nenad Blau
Neurology|October 29, 2003
Hypersensitivity pneumonitis possibly caused by riluzole therapy in ALSDavid Cassiman, Michiel Thomeer, Erik Verbeken, et al.
Orphanet Journal of Rare Diseases|April 29, 2014
Shining a light in the black box of orphan drug pricingEline Picavet, Thomas Morel, David Cassiman, et al.
Applied Health Economics and Health Policy|June 21, 2011
Drugs for rare diseases: influence of orphan designation status on priceEline Picavet, Marc Dooms, David Cassiman, et al.
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
Clinical Chemistry and Laboratory Medicine|April 17, 2012
Evaluation of the interference by homogentisic acid and other organic acids on the enzymatic and Jaffé method creatinine assaySteven Pauwels, David Cassiman, Pieter Vermeersch
Orphanet Journal of Rare Diseases|September 12, 2014
Reimbursement of orphan drugs in Belgium: what (else) matters?Eline Picavet, David Cassiman, Steven Simoens
Health Policy (Amsterdam, Netherlands)|September 20, 2012
Evaluating and improving orphan drug regulations in Europe: a Delphi policy studyEline Picavet, David Cassiman, Steven Simoens
Journal of Hepatology|March 8, 2024
Rare monogenic causes of steatotic liver disease masquerading as MASLDMartijn C G J Brouwers, David Cassiman
Journal of Inherited Metabolic Disease|October 2, 2021
Patents vs patients 1-0: The case of chenodeoxycholic acidSarah Marie Briké, Wouter Meersseman, David Cassiman
Gastroenterology|September 1, 2014
Hepatitis with brown pigment in the liverHannah van Malenstein, Louis Libbrecht, David Cassiman
Molecular Genetics and Metabolism|April 22, 2019
Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseasesCarlos R Ferreira, David Cassiman, Nenad Blau
Neurology|October 29, 2003
Hypersensitivity pneumonitis possibly caused by riluzole therapy in ALSDavid Cassiman, Michiel Thomeer, Erik Verbeken, et al.
Orphanet Journal of Rare Diseases|April 29, 2014
Shining a light in the black box of orphan drug pricingEline Picavet, Thomas Morel, David Cassiman, et al.
Applied Health Economics and Health Policy|June 21, 2011
Drugs for rare diseases: influence of orphan designation status on priceEline Picavet, Marc Dooms, David Cassiman, et al.
Pageof 21